Opioid overdose deaths rose to a new record in 2019 after dropping in 2018; CMS Administrator Seema Verma was investigated for mishandling taxpayer dollars; a new report shows the many risks seniors face if children return to school.
Fentanyl, synthetic opioid, cocaine, and methamphetamine overdoses caused the deaths of a record 71,000 Americans in 2019, reported the Associated Press, following a pre—coronavirus disease 2019 (COVID-19) dip in 2018, with fentanyl and synthetic opioids alone responsible for half. These data from the CDC also show an overall rise in overdose deaths in 30 states. Experts believe the US opioid crisis is rooted in prescriptions opioid painkillers and that despite eased government restrictions for buprenorphine and methadone enabling recovery, the pandemic could be increasing demand because more people are experiencing despair and anxiety.
Embattled CMS Administrator Seema Verma and her potential mishandling of government contracts were the subject of a recent 15-month investigation by the HHS inspector general, according to POLITICO. Verma, who is in charge of running Medicare and Medicaid, has already testified to there being nothing wrong with the contract dealings, in the investigation originally opened in April 2019. However, HHS’ 70-page report says she wasted taxpayer dollars by hand-picking outsiders to handle media appearances, speech writing, and event organization instead of using CMS’ more than 200 in-house communication officials.
Close to 3.3 million elderly individuals 65 years and older share their homes with children ages 5 to 18 years, while 4.1 million children of the same age share their homes with these older adults, detailed a new Kaiser Family Foundation report. The report raises concerns on children potentially contracting COVID-19 when schools reopen, and bringing it into their homes, although they have a lesser risk of infection and suffer milder symptoms. Older adults of color may face a higher risk in this regard, because they are more likely to live with school-aged children and the pandemic has already disproportionately affected their health.
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More